Loading...

NSS

NSRX

NASUS PHARMA LTD

(NSRX)

2026 6-K

Business Update

25 Mar '26

Positive Clinical Data

16 Mar '26

Shareholder Meeting Results

6 Mar '26

Virtual Shareholder Meeting

4 Mar '26

Funding Announcement

13 Feb '26

Private Placement

11 Feb '26

Shareholder Meeting Notice

29 Jan '26

Positive Interim Results

20 Jan '26

Financial Report

29 Dec '25

CEO Shareholder Letter

22 Dec '25

Leadership Appointment

20 Nov '25

Clinical Trial Launch

18 Nov '25

Corporate Presentation Release

3 Nov '25

Collaboration Update

8 Oct '25

IPO Update

30 Sep '25

Board Changes

5 Sep '25

External Links:

SEC

On March 25, 2026, Nasus Pharma Ltd. announced advancement of NS002 towards a pivotal study following positive Phase 2 results and shared their annual results. The company provided a business update in their press release, highlighting ongoing progress in their projects.

AI Assistant

NASUS PHARMA LTD

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.